A - Z index - S

The section presents an alphabetical listing of all pages of the website. Choose a letter from the links below to view all pages with titles that start with that letter. Alternatively view the sitemap, which lists all pages by their topic and placement in the navigation.

• SABRE

• SABRE communications

• SABRE: Frequently asked questions

• Safety alerts and reports relating to PIP breast implants

• Safety guidance

• Safety guidance on devices, other

• Safety information

• Safety issues

• Safety notices (devices)

• Safety of products: How we monitor

• Safety problems: Reporting

• Safety warnings

• Safety warnings and messages for herbal medicines

• Safety warnings and messages for medicines

• Safety warnings, alerts and recalls

• Salicylates and aspirin overdose

• Scenario 1

• Scenario 2

• Scenario 3

• Scenario 4

• Scientific advice for licence applicants

• Scientific advice request form

• Search tips for MHRA website

• Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors

• Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors

• Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors

• Selective Serotonin Reuptake Inhibitors Working Group of the Committee on Safety of Medicines

• Selective Serotonin Reuptake Inhibitors Working Group of the Committee on Safety of Medicines: Minutes

• Self-test kits

• Selling and supply of medicines

• Serious Adverse Blood Reactions & Events (SABRE)

• Serious and severe reactions

• Serious breaches of Good Clinical Practice reporting

• Shelley Dolan

• Side effects of medicines - FAQ

• Sir Gordon Duff

• Sitemap

• Smoking: Over-the-counter treatments to help smokers quit

• Somatic cell therapy

• SPC and PILs

• Speaker fees

• Speaker request form

• Speakers: FAQs

• Specific enquiries by MHRA Division

• Specific enquiries by subject

• SSRI learning module

• SSRI learning module: Case study

• SSRI learning module: Class members and licensed uses

• SSRI learning module: Exercise 1

• SSRI learning module: Further information

• SSRI learning module: Glossary

• SSRI learning module: Introduction to SSRIs

• SSRI learning module: Key points

• SSRI learning module: Prescribing points

• SSRI learning module: Principal risks

• SSRI learning module: Self-assessment test

• Staff data

• Staff profiles

• Standards and common technical specifications

• Stay connected with the MHRA

• Stay safe using natural remedies campaign

• Stephen Inglis

• Steroid medicines - Q&A

• Structure of the MHRA

• Subcommittees of Committee on Safety of Medicines

• Subject enquiries

• Submission formats accepted by MHRA

• Submission of labels and patient information leaflets

• Submission of parallel import applications

• Submission requirements for Active Substance Master Files

• Submissions on CD/DVD

• Submitting a notification for a trial: Additional information

• Submitting a notification for a trial: General information

• Submitting a notification for a trial: What to send

• Submitting an application to the MHRA

• Substantial amendments to your clinical trial authorisation: General information

• Summaries of product characteristics (SmPCs) of prescription only (POM) non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and over-the-counter (OTC) ibuprofen, for systemic administration

• Summaries of risk management plans

• Summaries of the safety/adverse effects of vaginal meshes for prolapse

• Summaries of the safety/adverse effects of vaginal tapes/slings for stress urinary incontinence

• Summary of Product Characteristics templates and fragments

• Sunset Clause

• Supplementary prescribing

• Surgical gowns, drapes and coverings

• Suspected defect online form

• Sustainable development action plan for the Medicines and Healthcare products Regulatory Agency 2009-2011

• Switch mode power supplies (SMPS)